# Suono Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suono-bio

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.suonobio.com
- Total disclosed funding: $8.5M
- Latest round: Series A (Mar 29, 2021)
- Investors on record: 5

## About

Suono Bio, Inc. is a biotechnology company focused on developing innovative solutions that enhance biological processes through proprietary technology. Their products aim to improve efficiency in various industries, including agriculture and pharmaceuticals.Founded in 2016 and headquartered in Cambridge, US, Suono Bio, Inc. specializes in bioengineering solutions designed to optimize metabolic pathways. The company has engaged in four significant deals to date, with the latest funding round, a Series A, completed on March 29, 2021, totaling USD 8.5 mn. The company was co-founded by Giovanni Traverso, who has a background in advancing biotechnological applications. Scott Kellogg serves as the CEO.Suono Bio develops advanced bioengineering tools that enhance metabolic processes across various organisms, targeting industries focused on sustainability, including agriculture and pharmaceuticals. The company markets its products to biotech firms, research institutions, and agricultural companies in North America and Europe, aiming to improve operational efficiency and product output.Suono Bio generates revenue through partnerships and direct sales of licenses for its proprietary bioengineering tools, often bundled with ongoing support services. Clients typically enter multi-year agreements that ensure access to the latest innovations, enhancing their operational capabilities. Collaborative projects with research institutions further diversify their revenue streams, supporting continuous research and development.Following their Series A funding of USD 8.5 mn on March 29, 2021, Suono Bio plans to advance its lead programs in inflammatory bowel disease and expand its product pipeline. The company aims to target new markets, particularly in North America and Europe, enhancing its reach by leveraging recent funding to support these initiatives.

## Funding rounds

- Series A, Mar 29, 2021, $8.5M — Mizuho Securities Principal Investment, Taiwania Capital, Axil Capital, Gutbrain Ventures
- Seed, Sep 18, 2017 — Engine Ventures

## Investors

- Engine Ventures (https://capitalatlas.ai/funds/engine-ventures) — Seed
- Mizuho Securities Principal Investment (https://capitalatlas.ai/funds/mizuho-securities-principal-investment) — Series A
- Taiwania Capital (https://capitalatlas.ai/funds/taiwania-capital) — Series A
- Axil Capital (https://capitalatlas.ai/funds/axil-capital) — Series A
- Gutbrain Ventures (https://capitalatlas.ai/funds/gutbrain-ventures) — Series A